208 related articles for article (PubMed ID: 37024284)
1. Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma.
Zacarías-Fluck MF; Massó-Vallés D; Giuntini F; González-Larreategui Í; Kaur J; Casacuberta-Serra S; Jauset T; Martínez-Martín S; Martín-Fernández G; Serrano Del Pozo E; Foradada L; Grueso J; Nonell L; Beaulieu ME; Whitfield JR; Soucek L
Genes Dev; 2023 Apr; 37(7-8):303-320. PubMed ID: 37024284
[TBL] [Abstract][Full Text] [Related]
2. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.
Stefan E; Bister K
Curr Top Microbiol Immunol; 2017; 407():117-151. PubMed ID: 28466200
[TBL] [Abstract][Full Text] [Related]
3. MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding.
Massó-Vallés D; Beaulieu ME; Jauset T; Giuntini F; Zacarías-Fluck MF; Foradada L; Martínez-Martín S; Serrano E; Martín-Fernández G; Casacuberta-Serra S; Castillo Cano V; Kaur J; López-Estévez S; Morcillo MÁ; Alzrigat M; Mahmoud L; Luque-García A; Escorihuela M; Guzman M; Arribas J; Serra V; Larsson LG; Whitfield JR; Soucek L
Cancer Res Commun; 2022 Feb; 2(2):110-130. PubMed ID: 36860495
[TBL] [Abstract][Full Text] [Related]
4. Distinct thresholds govern Myc's biological output in vivo.
Murphy DJ; Junttila MR; Pouyet L; Karnezis A; Shchors K; Bui DA; Brown-Swigart L; Johnson L; Evan GI
Cancer Cell; 2008 Dec; 14(6):447-57. PubMed ID: 19061836
[TBL] [Abstract][Full Text] [Related]
5. Measuring MYC-Mediated Metabolism in Tumorigenesis.
Tang HY; Goldman AR; Zhang X; Speicher DW; Dang CV
Methods Mol Biol; 2021; 2318():231-239. PubMed ID: 34019293
[TBL] [Abstract][Full Text] [Related]
6. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
[TBL] [Abstract][Full Text] [Related]
7. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.
Farrell AS; Pelz C; Wang X; Daniel CJ; Wang Z; Su Y; Janghorban M; Zhang X; Morgan C; Impey S; Sears RC
Mol Cell Biol; 2013 Aug; 33(15):2930-49. PubMed ID: 23716601
[TBL] [Abstract][Full Text] [Related]
8. The ARF tumor suppressor: keeping Myc on a leash.
Gregory MA; Qi Y; Hann SR
Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
[TBL] [Abstract][Full Text] [Related]
9. STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.
Bisikirska BC; Adam SJ; Alvarez MJ; Rajbhandari P; Cox R; Lefebvre C; Wang K; Rieckhof GE; Felsher DW; Califano A
Oncogene; 2013 Nov; 32(45):5283-91. PubMed ID: 23178486
[TBL] [Abstract][Full Text] [Related]
10. AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.
Kfoury A; Armaro M; Collodet C; Sordet-Dessimoz J; Giner MP; Christen S; Moco S; Leleu M; de Leval L; Koch U; Trumpp A; Sakamoto K; Beermann F; Radtke F
EMBO J; 2018 Mar; 37(5):. PubMed ID: 29440228
[TBL] [Abstract][Full Text] [Related]
11. MYC, Metabolism, and Cancer.
Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
[TBL] [Abstract][Full Text] [Related]
12. MYC on the path to cancer.
Dang CV
Cell; 2012 Mar; 149(1):22-35. PubMed ID: 22464321
[TBL] [Abstract][Full Text] [Related]
13. SNIP1: Myc's new helper in transcriptional activation.
Larsson LG
Mol Cell; 2006 Dec; 24(6):811-2. PubMed ID: 17189184
[TBL] [Abstract][Full Text] [Related]
14. MYC leads the way.
Venkateswaran N; Conacci-Sorrell M
Small GTPases; 2020 Mar; 11(2):86-94. PubMed ID: 29173017
[TBL] [Abstract][Full Text] [Related]
15. Myc's other life: stem cells and beyond.
Laurenti E; Wilson A; Trumpp A
Curr Opin Cell Biol; 2009 Dec; 21(6):844-54. PubMed ID: 19836223
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional control of DNA replication licensing by Myc.
Valovka T; Schönfeld M; Raffeiner P; Breuker K; Dunzendorfer-Matt T; Hartl M; Bister K
Sci Rep; 2013 Dec; 3():3444. PubMed ID: 24309437
[TBL] [Abstract][Full Text] [Related]
17. Skp2 regulates Myc protein stability and activity.
Kim SY; Herbst A; Tworkowski KA; Salghetti SE; Tansey WP
Mol Cell; 2003 May; 11(5):1177-88. PubMed ID: 12769843
[TBL] [Abstract][Full Text] [Related]
18. The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy.
Savino M; Annibali D; Carucci N; Favuzzi E; Cole MD; Evan GI; Soucek L; Nasi S
PLoS One; 2011; 6(7):e22284. PubMed ID: 21811581
[TBL] [Abstract][Full Text] [Related]
19. Myc's secret life without Max.
Gallant P; Steiger D
Cell Cycle; 2009 Dec; 8(23):3848-53. PubMed ID: 19887915
[TBL] [Abstract][Full Text] [Related]
20. MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination.
Wu X; Nelson M; Basu M; Srinivasan P; Lazarski C; Zhang P; Zheng P; Sandler AD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33757986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]